Endocrine Disruptors

Endocrine-disrupting chemicals may contribute to obesity with growing epidemiological and mechanistic evidence. The session covers BPA, phthalates, and PFAS evidence in obesity, microplastics and metabolic health, dietary-exposure routes, regulatory frameworks (FDA, EFSA), emerging epidemiological evidence including the EARTH and CHAMACOS cohorts. Discussion addresses the obesogen hypothesis, gestational exposure and offspring obesity, the role of EDCs in PCOS and male hypogonadism, occupational exposures, the policy levers including chemical regulation, the comparison of conventional vs organic diets in EDC exposure, and the integration of environmental medicine in obesity practice.